Cargando…
Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer
gC1qR is highly expressed in breast cancer and plays a role in cancer cell proliferation. This study explored therapy with gC1qR monoclonal antibody 60.11, directed against the C1q binding domain of gC1qR, in a murine orthotopic xenotransplant model of triple negative breast cancer. MDA231 breast ca...
Autores principales: | Peerschke, Ellinor I., de Stanchina, Elisa, Chang, Qing, Manova-Todorova, Katia, Barlas, Afsar, Savitt, Anne G., Geisbrecht, Brian V., Ghebrehiwet, Berhane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709104/ https://www.ncbi.nlm.nih.gov/pubmed/33036212 http://dx.doi.org/10.3390/antib9040051 |
Ejemplares similares
-
gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma
por: Peerschke, Ellinor, et al.
Publicado: (2020) -
Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis
por: Sünderhauf, Annika, et al.
Publicado: (2021) -
Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy
por: Li, Xiaoyu, et al.
Publicado: (2019) -
Soluble gC1qR in Blood and Body Fluids: Examination in a Pancreatic Cancer Patient Cohort
por: Peerschke, Ellinor IB, et al.
Publicado: (2015) -
Heterozygous P32/C1QBP/HABP1 Polymorphism rs56014026 Reduces Mitochondrial Oxidative Phosphorylation and Is Expressed in Low-grade Colorectal Carcinomas
por: Raschdorf, Annika, et al.
Publicado: (2021)